Cargando…

Clarithromycin is an effective immunomodulator when administered late in experimental pyelonephritis by multidrug-resistant Pseudomonas aeruginosa

BACKGROUND: To apply clarithromycin as an immunomodulatory treatment in experimental urosepsis by multidrug-resistant Pseudomonas aeruginosa. METHODS: Acute pyelonephritis was induced in 40 rabbits after inoculation of the test isolate in the renal pelvis. Therapy was administered upon signs of seps...

Descripción completa

Detalles Bibliográficos
Autores principales:	Giamarellos-Bourboulis, Evangelos J, Antonopoulou, Anastasia, Raftogiannis, Maria, Koutoukas, Pantelis, Tsaganos, Thomas, Tziortzioti, Vassiliki, Panagou, Charalambos, Adamis, Theodoros, Giamarellou, Helen
Formato:	Texto
Lenguaje:	English
Publicado:	BioMed Central 2006
Materias:	Research Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC1397846/ https://www.ncbi.nlm.nih.gov/pubmed/16504031 http://dx.doi.org/10.1186/1471-2334-6-31

Ejemplares similares

Clarithromycin reverses sepsis-induced immunoparalysis of monocytes
por: Raftogiannis, M, et al.
Publicado: (2009)

The Importance of Fever as a Predictive Symptom for the Potency of Host's Monocytes to Release Pro- and Anti-Inflammatory Mediators
por: Kyriakopoulou, Magdalini, et al.
Publicado: (2008)

Early changes of CD4-positive lymphocytes and NK cells in patients with severe Gram-negative sepsis
por: Giamarellos-Bourboulis, Evangelos J, et al.
Publicado: (2006)

Immunomodulatory effects of esmolol in a septic animal model due to multidrug-resistant Pseudomonas aeruginosa pyelonephritis
por: Dimopoulos, G, et al.
Publicado: (2008)

Effect of the novel influenza A (H1N1) virus in the human immune system
por: Antonopoulou, A, et al.
Publicado: (2009)

Effect of the Novel Influenza A (H1N1) Virus in the Human Immune System
por: Giamarellos-Bourboulis, Evangelos J., et al.
Publicado: (2009)

IFNγ prolongs survival in experimental Escherichia coli pyelonephritis: implications for favorable phagocytosis
por: Katsaris, M, et al.
Publicado: (2011)

Interferon-gamma reverses sepsis-induced immunoparalysis of monocytes in vitro
por: Mouktaroudi, M, et al.
Publicado: (2010)

Early apoptosis of blood monocytes in the septic host: is it a mechanism of protection in the event of septic shock?
por: Giamarellos-Bourboulis, Evangelos J, et al.
Publicado: (2006)

Effect of clarithromycin in patients with Gram-negative sepsis: subgroup analysis of a randomized trial
por: Giamarellos-Bourboulis, E, et al.
Publicado: (2014)

In Vitro Activity of Oral Cephalosporins (Cefprozil and Cefixime) Against Ciprofloxacin-Resistant Enterobacteriaceae from Community-Acquired Urinary-Tract Infections
por: Pistiki, Aikaterini, et al.
Publicado: (2015)

Compartmentalization of lipid peroxidation in sepsis by multidrug-resistant gram-negative bacteria: experimental and clinical evidence
por: Toufekoula, Chryssoula, et al.
Publicado: (2013)

Immunomodulatory intervention in sepsis by multidrug-resistant Pseudomonas aeruginosa with thalidomide: an experimental study
por: Giamarellos-Bourboulis, Evangelos J, et al.
Publicado: (2005)

Kinetics of progenitor hemopoetic stem cells in sepsis: Correlation with patients survival?
por: Tsaganos, Thomas, et al.
Publicado: (2006)

Decrease of CD4-lymphocytes and apoptosis of CD14-monocytes are characteristic alterations in sepsis caused by ventilator-associated pneumonia: results from an observational study
por: Pelekanou, Aimilia, et al.
Publicado: (2009)

Staphylococcus Aureus Osteomyelitis as an Inducer of Tolerance to Escherichia Coli Pyelonephritis: an Experimental Study
por: Goumenos, Stavros, et al.
Publicado: (2020)

Clarithromycin as an immunomodulator in sepsis: still a (IN)CLASS act
por: Snow, Timothy Arthur Chandos, et al.
Publicado: (2022)

Bacterial translocation primes proinflammatory responses and is connected to early death in an experimental model of lethal injury
por: Baxevanos, N, et al.
Publicado: (2013)

Does leukocyte apoptosis play any role in the pathogenesis of experimental pancreatitis?
por: Zotos, D, et al.
Publicado: (2011)

Diagnostic value of triggering receptor expressed on myeloid cells-1 and C-reactive protein for patients with lung infiltrates: an observational study
por: Porfyridis, Ilias, et al.
Publicado: (2010)

Inhibition of caspase-1 activation in gram-negative sepsis and experimental endotoxemia
por: Giamarellos-Bourboulis, Evangelos J, et al.
Publicado: (2011)

Bacterial load plays a crucial role for survival in experimental peritonitis and modulates immunoparalysis of monocytes
por: Atmatzidis, S, et al.
Publicado: (2010)

Prognostic Role of Soluble Urokinase Plasminogen Activator Receptor at the Emergency Department: A Position Paper by the Hellenic Sepsis Study Group
por: Velissaris, Dimitrios, et al.
Publicado: (2020)

Anti-inflammatory and immunomodulating effects of clarithromycin in patients with cystic fibrosis lung disease.
por: Pukhalsky, Alexander L, et al.
Publicado: (2004)

Risk assessment in sepsis: a new prognostication rule by APACHE II score and serum soluble urokinase plasminogen activator receptor
por: Giamarellos-Bourboulis, Evangelos J, et al.
Publicado: (2012)

Randomized, controlled, multicentre clinical trial of the antipyretic effect of intravenous paracetamol in patients admitted to hospital with infection
por: Tsaganos, Thomas, et al.
Publicado: (2016)

Editorial Introduction to the Supplement “Diagnosis of Infectious Diseases by Detection of Microbial Pathogens: A Joint Session Between HemoSpec FrameWork 7 Consortium with COST Action BM1401 Raman4Clinics Working Group 2”
por: Giamarellos-Bourboulis, Evangelos J.
Publicado: (2018)

Complex immune deregulation in severe COVID-19: More than a mechanism of pathogenesis
por: Giamarellos-Bourboulis, Evangelos J.
Publicado: (2021)

Decreased cytokine production by mononuclear cells after severe gram-negative infections: early clinical signs and association with final outcome
por: Antonakos, Nikolaos, et al.
Publicado: (2017)

Small intestinal bacterial overgrowth is associated with irritable bowel syndrome and is independent of proton pump inhibitor usage
por: Giamarellos-Bourboulis, Evangelos J., et al.
Publicado: (2016)

Immunomodulation and Reduction of Thromboembolic Risk in Hospitalized COVID-19 Patients: Systematic Review and Meta-Analysis of Randomized Trials
por: Sagris, Dimitrios, et al.
Publicado: (2021)

Multiple trauma is linked with reversal of immunoparalysis and provides survival benefit from Pseudomonas aeruginosa
por: Mandragos, E, et al.
Publicado: (2014)

Early alterations of the innate and adaptive immune statuses in sepsis according to the type of underlying infection
por: Gogos, Charalambos, et al.
Publicado: (2010)

The complex pathogenesis of bacteremia: From antimicrobial clearance mechanisms to the genetic background of the host
por: Christaki, Eirini, et al.
Publicado: (2014)

Macrophage Activation-Like Syndrome: A Distinct Entity Leading to Early Death in Sepsis
por: Karakike, Eleni, et al.
Publicado: (2019)

Antimicrobial Stewardship Using Biomarkers: Accumulating Evidence for the Critically Ill
por: Kyriazopoulou, Evdoxia, et al.
Publicado: (2022)

BioFire(®) FilmArray(®) Pneumonia Panel for Severe Lower Respiratory Tract Infections: Subgroup Analysis of a Randomized Clinical Trial
por: Kyriazopoulou, Evdoxia, et al.
Publicado: (2021)

Benefits of Synbiotic 2000 Forte in critically ill patients: a randomized controlled trial
por: Voudouris, A, et al.
Publicado: (2005)

Obesity as a Consequence of Gut Bacteria and Diet Interactions
por: Kotzampassi, Katerina, et al.
Publicado: (2014)

Reply to Radermacher et al. on “Serum Hydrogen Sulfide and Outcome Association in Pneumonia by the SARS-CoV-2 Coronavirus”
por: Renieris, Georgios, et al.
Publicado: (2021)

Cannot write session to /tmp/vufind_sessions/sess_b9foc2mrgp7f072agcr3pq1e2f